PA Capital’s Kura Oncology KURA Stock Holding History

PA Capital’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$234K	Sell	7,642 -37,066	-83%	-$818K	0.16%	152
2020 Q2	$729K	Sell	44,708 -55,621	-55%	-$802K	0.53%	70
2020 Q1	$998K	Buy	100,329 +36,270	+57%	+$415K	0.88%	38
2019 Q4	$881K	Buy	64,059 +9,629	+18%	+$143K	0.78%	47
2019 Q3	$826K	Buy	54,430 +4,271	+9%	+$76K	0.81%	47
2019 Q2	$988K	Buy	+50,159	New	+$833K	0.9%	39
2019 Q1	–	Sell	-17,250	Closed	-$242K	–	126
2018 Q4	$242K	Buy	+17,250	New	+$229K	0.26%	90

Other funds holding KURA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

PA Capital's KURA Position: Q3 2020 in Review

PA Capital reduced its Kura Oncology (KURA) stake by 83% in Q3 2020, selling an estimated $818K and leaving 7,642 shares worth $234K. The position accounts for 0.16% of the portfolio, ranked #152.

PA Capital first reported a position in KURA in Q4 2018 and has held it in 7 quarters since. The position peaked at $998K in Q1 2020. 162 funds tracked by Wall St. Rank hold KURA as of Q3 2020.

PA Capital held 7,642 shares of Kura Oncology worth $234K as of Q3 2020.
PA Capital sold 37,066 Kura Oncology shares in Q3 2020, an estimated $818K.
Kura Oncology made up 0.16% of PA Capital's portfolio in Q3 2020, its #152 holding.
PA Capital first reported a position in Kura Oncology in Q4 2018 and has held it in 7 quarters since.
PA Capital's Kura Oncology position peaked at $998K in Q1 2020.
162 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2020.

Based on PA Capital's 13F filing for Q3 2020, filed 13 Nov 2020.